MedPath

Alliance for Clinical Trials in Oncology

Alliance for Clinical Trials in Oncology logo
πŸ‡ΊπŸ‡ΈUnited States
Ownership
Private
Established
2011-01-01
Employees
251
Market Cap
-
Website
https://www.allianceforclinicaltrialsinoncology.org

Ceramide Cream in Treating Women With Cutaneous Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
Drug: ceramide
First Posted Date
2004-03-25
Last Posted Date
2016-12-06
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
26
Registration Number
NCT00008320
Locations
πŸ‡ΊπŸ‡Έ

CCOP - Carle Cancer Center, Urbana, Illinois, United States

πŸ‡ΊπŸ‡Έ

Siouxland Hematology-Oncology, Sioux City, Iowa, United States

πŸ‡ΊπŸ‡Έ

Medcenter One Health System, Bismarck, North Dakota, United States

and more 10 locations

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

Phase 3
Completed
Conditions
Lymphoma
Unspecified Childhood Solid Tumor, Protocol Specific
Chronic Myeloproliferative Disorders
Nausea and Vomiting
Precancerous Condition
Myelodysplastic Syndromes
Leukemia
Multiple Myeloma and Plasma Cell Neoplasm
Small Intestine Cancer
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
Drug: ondansetron
Other: placebo
First Posted Date
2004-03-25
Last Posted Date
2016-07-06
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
100
Registration Number
NCT00006348
Locations
πŸ‡ΊπŸ‡Έ

CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States

πŸ‡ΊπŸ‡Έ

Rapid City Regional Hospital, Rapid City, South Dakota, United States

πŸ‡ΊπŸ‡Έ

Altru Health Systems, Grand Forks, North Dakota, United States

and more 9 locations

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
Interventions
First Posted Date
2004-03-24
Last Posted Date
2016-07-14
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
73
Registration Number
NCT00005972
Locations
πŸ‡ΊπŸ‡Έ

Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, United States

πŸ‡ΊπŸ‡Έ

University of Chicago Cancer Research Center, Chicago, Illinois, United States

πŸ‡ΊπŸ‡Έ

Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States

and more 47 locations

Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer

Phase 1
Completed
Conditions
Cancer
Interventions
Drug: capecitabine
Radiation: radiation therapy
First Posted Date
2004-03-15
Last Posted Date
2016-07-06
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
51
Registration Number
NCT00003704
Locations
πŸ‡ΊπŸ‡Έ

CentraCare Clinic, Saint Cloud, Minnesota, United States

πŸ‡¨πŸ‡¦

Allan Blair Cancer Centre, Regina, Saskatchewan, Canada

πŸ‡ΊπŸ‡Έ

Siouxland Hematology-Oncology, Sioux City, Iowa, United States

and more 15 locations

Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2004-03-09
Last Posted Date
2016-12-13
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
70
Registration Number
NCT00079118
Locations
πŸ‡ΊπŸ‡Έ

Kenton Oncology, Incorporated, Kenton, Ohio, United States

πŸ‡ΊπŸ‡Έ

McDonough District Hospital, Macomb, Illinois, United States

πŸ‡ΊπŸ‡Έ

Hurley Medical Center, Flint, Michigan, United States

and more 156 locations

Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases

Phase 3
Completed
Conditions
Metastatic Cancer
Prostate Cancer
Interventions
Drug: zoledronic acid
Other: placebo
Drug: androgen deprivation therapy
Drug: GnRH agonist
Dietary Supplement: Calcium supplement
Dietary Supplement: Vitamin D
First Posted Date
2004-03-09
Last Posted Date
2020-05-12
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
645
Registration Number
NCT00079001
Locations
πŸ‡ΊπŸ‡Έ

Good Samaritan Hospital of Maryland, Baltimore, Maryland, United States

πŸ‡ΊπŸ‡Έ

Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States

πŸ‡ΊπŸ‡Έ

Fisher-Titus Medical Center, Norwalk, Ohio, United States

and more 237 locations

Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas

Phase 2
Completed
Conditions
Pancreatic Cancer
Interventions
First Posted Date
2004-03-08
Last Posted Date
2016-07-06
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
48
Registration Number
NCT00006467
Locations
πŸ‡ΊπŸ‡Έ

CCOP - Carle Cancer Center, Urbana, Illinois, United States

πŸ‡ΊπŸ‡Έ

Siouxland Hematology-Oncology, Sioux City, Iowa, United States

πŸ‡ΊπŸ‡Έ

CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States

and more 13 locations

Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach

Phase 2
Completed
Conditions
Gastric Cancer
Esophageal Cancer
Interventions
First Posted Date
2004-03-03
Last Posted Date
2016-07-14
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
47
Registration Number
NCT00004235
Locations
πŸ‡ΊπŸ‡Έ

CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States

πŸ‡ΊπŸ‡Έ

Medcenter One Health System, Bismarck, North Dakota, United States

πŸ‡ΊπŸ‡Έ

CCOP - Geisinger Clinic and Medical Center, Danville, Pennsylvania, United States

and more 16 locations

Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2004-03-01
Last Posted Date
2016-07-14
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
104
Registration Number
NCT00003351
Locations
πŸ‡ΊπŸ‡Έ

CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States

πŸ‡ΊπŸ‡Έ

CCOP - Wichita, Wichita, Kansas, United States

πŸ‡ΊπŸ‡Έ

Siouxland Hematology-Oncology, Sioux City, Iowa, United States

and more 19 locations

Capecitabine in Treating Patients With Malignant Mesothelioma

Phase 2
Completed
Conditions
Malignant Mesothelioma
Interventions
First Posted Date
2004-02-25
Last Posted Date
2016-07-14
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
27
Registration Number
NCT00004183
Locations
πŸ‡ΊπŸ‡Έ

University of Chicago Cancer Research Center, Chicago, Illinois, United States

πŸ‡ΊπŸ‡Έ

CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse, New York, United States

πŸ‡ΊπŸ‡Έ

University of Illinois at Chicago Health Sciences Center, Chicago, Illinois, United States

and more 47 locations
Β© Copyright 2025. All Rights Reserved by MedPath